Why Pathkey.AI (ASX:PKY) is moving from marketing software into AI-assisted chip design

Sonal Goyal

03 November 2026 09:09 PM AEDT

Why Pathkey.AI (ASX:PKY) is moving from marketing software into AI-assisted chip design

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Pathkey.AI (ASX:PKY) gained control of Chipforge, an AI-native chip design and verification platform, on 23 June 2026, pivoting away from Marketing and clinical-trial software.
Chipforge secured its first commercial contract in August 2026 for a US$50,000 fixed fee with an unnamed Australian industrial automation company, ahead of the platform's general release.
Sam Weiss, former Altium chairman, was appointed strategic adviser and is due to receive up to 40 million performance rights after a A$2.8 million Placement at A$0.028 per share.
Cash was A$5.83 million at 30 September 2026, with estimated funding of about 5.48 quarters at the current Burn Rate of A$1.06 million per quarter.

Pathkey.AI Limited (ASX:PKY) has moved from a niche marketing and clinical-trial software Business towards AI-assisted chip design, and that shift explains why the company is drawing attention in the information technology sector. On 23 June 2026 it gained control of Chipforge, a Singapore-incorporated platform for designing and verifying chips.

What the business does

The ASX describes Pathkey.AI as the owner and operator of a user-generated content marketing platform. Its Quarterly Report also describes TrialKey, a tool that assesses draft clinical-trial protocols, benchmarks competitors and compares indicative costs.

Chipforge adds a third strand. The company calls it an AI-native platform covering design intent, generated register-transfer-level code, verification, simulation and sign-off, aimed at FPGA and ASIC targets.

The first commercial test

On 11 August 2026 Pathkey announced Chipforge's first commercial contract, ahead of the platform's general release. The customer is an unnamed Australian industrial automation company, and the fixed fee is US$50,000, payable 40 per cent on Phase A acceptance and 60 per cent on Phase B acceptance.

The work covers the intelligence unit for an automated cleaning and condition-monitoring system, demonstrated on an FPGA board. Pathkey itself said the contract was not financially material, so its value lies in proving the workflow with a paying client rather than in the revenue.

Money in and money out

For the year to 30 June 2026 (FY26), the Appendix 4E reported Revenue of $47,632 and a loss after tax of $3,652,677, against $1,447,743 a year earlier. The report does not label the currency, and the auditor's opinion was unmodified.

The quarter ended 30 September 2026 shows the scale of the early-stage burn. Receipts from customers were A$10,000 and net operating cash outflow was A$1.063 million, including A$293,000 on research and development.

Financing brought in A$3.631 million, mostly from a A$2.8 million placement at A$0.028 per share (100 million shares) announced on 12 August 2026. Cash at 30 September 2026 was A$5.83 million, with no Debt or unused facilities, and the company estimated about 5.48 quarters of funding at that rate of spending.

The placement was cornerstoned by Sam Weiss, who was appointed strategic advisor. Pathkey says he chaired ASX-listed Altium from 2007 to 2024, a period that ended with its Acquisition by Renesas Electronics. On 10 September 2026 it also named Associate Professor Anupam Chattopadhyay to a new advisory board.

Such appointments add industry experience and credibility, but they do not themselves create revenue or customers. Mr Weiss is due to receive up to 40 million performance rights, vesting in four equal tranches after 6, 12, 24 and 36 months of service, subject to Shareholder approval.

Risks to weigh

Revenue is tiny against costs, so further Capital raising is plausible, and each issue of shares or Options dilutes existing holders. The company itself cautions that signed contracts and development priorities do not guarantee product release, customer acceptance or recurring cash receipts.

Chipforge also competes in a field dominated by large, well-established design-software vendors, and its longer-term ASIC ambitions are separate from, and harder than, the current FPGA work. Related parties received A$212,000 in the quarter for Research and Development services, which is disclosed in the report and worth monitoring closely.

What to watch next

The Annual General Meeting is on 5 November 2026 in West Perth. Resolutions include ratifying the August placement, approving Mr Weiss's performance rights, adopting a new employee incentive plan and lifting the non-executive director fee pool from A$300,000 to A$600,000.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.